Try these holistic remedies to get relief for irritated skin.

The global hand eczema treatment market is projected to experience robust growth, with a market value of USD 53 million in ...

The US FDA has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...

The following is a summary of “Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic ...

Switzerland’s Galderma has won US Food and Drug Administration (FDA) approval for the use of Nemluvio (nemolizumab) for ...

She was prescribed steroid creams, but this has caused the 27-year-old more agony as she now suffers from topical steroid withdrawal ... such as eczema. At its worst she is unable to able to ...

This article reviews eczema on the backs of knees, symptoms, possible complications, causes, diagnosis treatments, prevention, and outlook. However, it is also important to note that other skin ...

Dec. 17, 2024 -- The FDA last week approved Nemluvio for treating moderate to severe atopic dermatitis, a type of eczema, in people aged 12 or older. Nemluvio is to be used with topical ...

Nonspecific anti-inflammatories like steroids might be entirely sidelined for mild-to-moderate chronic hand eczema now that three targeted topical agents are available.

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

Current treatments for chronic hand eczema (CHE) generally fall into two ... “Overall, current treatment options for CHE, such as topical corticosteroids, emollients, immunosuppressants, and ...